210 related articles for article (PubMed ID: 17215448)
21. Effect of oxidized regenerated cellulose (Interceed) on the expression of tissue plasminogen activator and plasminogen activator inhibitor-1 in human peritoneal fibroblasts and mesothelial cells.
Gago LA; Saed G; Elhammady E; Diamond MP
Fertil Steril; 2006 Oct; 86(4 Suppl):1223-7. PubMed ID: 17008148
[TBL] [Abstract][Full Text] [Related]
22. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M; Collen D; Lijnen HR
Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
[TBL] [Abstract][Full Text] [Related]
23. [Expression of plasminogen activator inhibitor-1 and tissue plasminogen activator in the kidney of KKAy mice with type 2 diabetes].
Chen LM; Li XW; Huang LW; Li Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):344-8. PubMed ID: 16038272
[TBL] [Abstract][Full Text] [Related]
24. The role of the fibrinolytic system in corneal angiogenesis.
Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
[TBL] [Abstract][Full Text] [Related]
25. Administration of exogenous tissue plasminogen activator reduces oedema in mice lacking the tissue plasminogen activator gene.
Stringer KA; Dunn JS; Gustafson DL
Clin Exp Pharmacol Physiol; 2004; 31(5-6):327-30. PubMed ID: 15191406
[TBL] [Abstract][Full Text] [Related]
26. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.
Zaitsev S; Danielyan K; Murciano JC; Ganguly K; Krasik T; Taylor RP; Pincus S; Jones S; Cines DB; Muzykantov VR
Blood; 2006 Sep; 108(6):1895-902. PubMed ID: 16735601
[TBL] [Abstract][Full Text] [Related]
27. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis.
Izuhara Y; Takahashi S; Nangaku M; Takizawa S; Ishida H; Kurokawa K; van Ypersele de Strihou C; Hirayama N; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):672-7. PubMed ID: 18239154
[TBL] [Abstract][Full Text] [Related]
29. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms.
Cacquevel M; Launay S; Castel H; Benchenane K; Chéenne S; Buée L; Moons L; Delacourte A; Carmeliet P; Vivien D
Neurobiol Dis; 2007 Aug; 27(2):164-73. PubMed ID: 17566751
[TBL] [Abstract][Full Text] [Related]
30. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
Rupin A; Gaertner R; Mennecier P; Richard I; Benoist A; De Nanteuil G; Verbeuren TJ
Thromb Res; 2008; 122(2):265-70. PubMed ID: 18177924
[TBL] [Abstract][Full Text] [Related]
31. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury.
Roelofs JJ; Rouschop KM; Leemans JC; Claessen N; de Boer AM; Frederiks WM; Lijnen HR; Weening JJ; Florquin S
J Am Soc Nephrol; 2006 Jan; 17(1):131-40. PubMed ID: 16291841
[TBL] [Abstract][Full Text] [Related]
32. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
33. Brain endothelial hemostasis regulation by pericytes.
Kim JA; Tran ND; Li Z; Yang F; Zhou W; Fisher MJ
J Cereb Blood Flow Metab; 2006 Feb; 26(2):209-17. PubMed ID: 16015279
[TBL] [Abstract][Full Text] [Related]
34. Protection by alpha2-macroglobulin of tissue plasminogen activator against inhibition by plasminogen activator inhibitor-1.
Ieko M; Sawada K; Yasukouchi T; Sakurama S; Tohma Y; Shiroshita K; Kurosawa S; Ohmoto A; Kohno M; Satoh M; Koike T
Br J Haematol; 1997 Apr; 97(1):214-8. PubMed ID: 9136968
[TBL] [Abstract][Full Text] [Related]
35. Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection.
Roelofs JJ; Rouschop KM; Teske GJ; Wagenaar GT; Claessen N; Weening JJ; van der Poll T; Florquin S
Nephrol Dial Transplant; 2009 Mar; 24(3):801-8. PubMed ID: 18842674
[TBL] [Abstract][Full Text] [Related]
36. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
Abderrahmani R; François A; Buard V; Benderitter M; Sabourin JC; Crandall DL; Milliat F
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):942-8. PubMed ID: 19480973
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue.
Virtanen OJ; Sirén V; Multanen J; Färkkilä M; Leivo I; Vaheri A; Koskiniemi M
Eur J Oral Sci; 2006 Feb; 114(1):22-6. PubMed ID: 16460337
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Zhu Y; Carmeliet P; Fay WP
Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activators are involved in the degradation of bone by osteoclasts.
Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
[TBL] [Abstract][Full Text] [Related]
40. Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis.
Numaguchi Y; Ishii M; Kubota R; Morita Y; Yamamoto K; Matsushita T; Okumura K; Murohara T
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2102-8. PubMed ID: 19745198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
